- Home
- CELC vs CLPT Comparison
CELC vs CLPT Comparison
Compare CELC & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELC
- CLPT
- Stock Information
- Founded
- CELC 2011
- CLPT 1998
- Country
- CELC United States
- CLPT United States
- Employees
- CELC N/A
- CLPT N/A
- Industry
- CELC Medical Specialities
- CLPT Medical/Dental Instruments
- Sector
- CELC Health Care
- CLPT Health Care
- Exchange
- CELC Nasdaq
- CLPT Nasdaq
- Market Cap
- CELC 489.7M
- CLPT 412.7M
- IPO Year
- CELC 2017
- CLPT N/A
- Fundamental
- Price
- CELC $10.93
- CLPT $15.04
- Analyst Decision
- CELC Strong Buy
- CLPT Strong Buy
- Analyst Count
- CELC 6
- CLPT 2
- Target Price
- CELC $29.17
- CLPT $12.00
- AVG Volume (30 Days)
- CELC 356.6K
- CLPT 198.6K
- Earning Date
- CELC 11-14-2024
- CLPT 03-11-2025
- Dividend Yield
- CELC N/A
- CLPT N/A
- EPS Growth
- CELC N/A
- CLPT N/A
- EPS
- CELC N/A
- CLPT N/A
- Revenue
- CELC N/A
- CLPT $30,429,000.00
- Revenue This Year
- CELC N/A
- CLPT $35.56
- Revenue Next Year
- CELC N/A
- CLPT $21.86
- P/E Ratio
- CELC N/A
- CLPT N/A
- Revenue Growth
- CELC N/A
- CLPT 36.34
- 52 Week Low
- CELC $10.35
- CLPT $5.11
- 52 Week High
- CELC $22.19
- CLPT $17.47
- Technical
- Relative Strength Index (RSI)
- CELC 35.65
- CLPT 51.20
- Support Level
- CELC $10.35
- CLPT $14.75
- Resistance Level
- CELC $13.80
- CLPT $15.93
- Average True Range (ATR)
- CELC 0.83
- CLPT 0.78
- MACD
- CELC -0.19
- CLPT -0.18
- Stochastic Oscillator
- CELC 16.20
- CLPT 33.78
About CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are highly differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, and ClearPoint Therapeutic Solutions.